Anna Schuh, Associate Professor for Molecular Diagnostics, University of Oxford explains how new technology and Big Data help doctors analyse genetic information of patients with rare inherited diseases or cancers including blood cancers, and the impact on the treatment and management of these conditions.

The importance of genetic diagnosis has been recognised by the Department of Health and the National Institute for Health Research, the research funding arm of the NHS. The 100,000 Genome Project has been set up to sequence the entire genome of 100,000 patients in the NHS before 2018.

Initiatives at the University of Oxford and the Oxford BRC have played an important role in getting this ambitious NHS transformation programme off the ground and the talk will provide insight into some of these.

To book to attend please email ouhmembers@ouh.nhs.uk or call 01865 231472.